Latest Insider Transactions at Maravai Lifesciences Holdings, Inc. (MRVI)
This section provides a real-time view of insider transactions for Maravai Lifesciences Holdings, Inc. (MRVI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MARAVAI LIFESCIENCES HOLDINGS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MARAVAI LIFESCIENCES HOLDINGS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2024
|
Kevin Herde Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,664
-0.77%
|
$13,320
$5.48 P/Share
|
|
Feb 15
2024
|
Kurt Oreshack General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,322
-1.01%
|
$11,610
$5.48 P/Share
|
|
Jan 16
2024
|
William E. Martin Iii Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
758,415
+42.16%
|
-
|
|
Jan 16
2024
|
Andrew Burch Officer |
BUY
Grant, award, or other acquisition
|
Direct |
295,782
+40.38%
|
-
|
|
Jan 16
2024
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,277
+42.1%
|
-
|
|
Jan 16
2024
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
166,852
+42.02%
|
-
|
|
Jan 16
2024
|
Peter Michael Leddy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,277
+39.52%
|
-
|
|
Jan 16
2024
|
Rebecca Buzzeo Officer |
BUY
Grant, award, or other acquisition
|
Direct |
288,198
+43.82%
|
-
|
|
Jan 16
2024
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
189,604
+41.68%
|
-
|
|
Jan 16
2024
|
Carl Hull Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,842
+20.43%
|
-
|
|
Nov 15
2023
|
Rebecca Buzzeo Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,549
-5.3%
|
$22,745
$5.19 P/Share
|
|
Oct 31
2023
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,729
+2.23%
|
$8,645
$5.83 P/Share
|
|
Oct 31
2023
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,861
+1.94%
|
$9,305
$5.83 P/Share
|
|
Oct 31
2023
|
Peter Michael Leddy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
449
+0.34%
|
$2,245
$5.83 P/Share
|
|
Oct 16
2023
|
William E. Martin Iii Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
66,197
-19.02%
|
$463,379
$7.54 P/Share
|
|
Jul 20
2023
|
John A De Ford Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,901
+50.0%
|
-
|
|
Jul 17
2023
|
Anat Ashkenazi Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+37.43%
|
-
|
|
Jul 17
2023
|
Murali Prahalad Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+34.87%
|
-
|
|
Jul 17
2023
|
Sean Laurence Cunningham Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+45.91%
|
-
|
|
Jul 17
2023
|
Peter Michael Leddy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,578
-4.04%
|
$66,936
$12.52 P/Share
|
|
Jul 17
2023
|
Jessica Hopfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+21.03%
|
-
|
|
Jul 17
2023
|
Benjamin James Daverman Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+45.91%
|
-
|
|
Jul 17
2023
|
Luke Joseph Marker Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+45.91%
|
-
|
|
Jul 17
2023
|
Constantine S Mihas Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+45.91%
|
-
|
|
Jul 17
2023
|
Susannah Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+28.53%
|
-
|
|
Jul 17
2023
|
Gregory T Lucier Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+30.33%
|
-
|
|
Apr 28
2023
|
Peter Michael Leddy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,920
+1.37%
|
$21,120
$11.72 P/Share
|
|
Apr 28
2023
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,394
+1.85%
|
$15,334
$11.72 P/Share
|
|
Apr 28
2023
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,014
+1.57%
|
$11,154
$11.72 P/Share
|
|
Apr 28
2023
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
874
+0.94%
|
$9,614
$11.72 P/Share
|
|
Mar 15
2023
|
Carl Hull Director |
BUY
Grant, award, or other acquisition
|
Direct |
147,638
+40.21%
|
-
|
|
Mar 15
2023
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,775
+43.45%
|
-
|
|
Mar 15
2023
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,507
+44.29%
|
-
|
|
Mar 15
2023
|
Peter Michael Leddy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,507
+34.77%
|
-
|
|
Mar 15
2023
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
38,386
+38.1%
|
-
|
|
Feb 15
2023
|
Christine Dolan Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,956
-10.41%
|
$29,340
$15.23 P/Share
|
|
Feb 15
2023
|
Kurt Oreshack General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,312
-8.8%
|
$34,680
$15.23 P/Share
|
|
Feb 15
2023
|
Kevin Herde Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,611
-12.26%
|
$39,165
$15.23 P/Share
|
|
Feb 15
2023
|
Carl Hull Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,719
-11.91%
|
$145,785
$15.23 P/Share
|
|
Feb 15
2023
|
Brian Neel Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,312
-12.31%
|
$34,680
$15.23 P/Share
|
|
Jan 22
2023
|
Gtcr Investment Xi LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
4,575,170
-3.7%
|
-
|
|
Oct 31
2022
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
351
+1.32%
|
$4,914
$14.11 P/Share
|
|
Oct 31
2022
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
478
+2.2%
|
$6,692
$14.11 P/Share
|
|
Oct 31
2022
|
Brian Neel Officer |
BUY
Grant, award, or other acquisition
|
Direct |
329
+1.72%
|
$4,606
$14.11 P/Share
|
|
Oct 17
2022
|
William E. Martin Iii Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
348,055
+44.79%
|
-
|
|
Jul 15
2022
|
Peter Michael Leddy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,498
+50.0%
|
-
|
|
Apr 29
2022
|
Brian Neel Officer |
BUY
Grant, award, or other acquisition
|
Direct |
572
+3.01%
|
$12,584
$22.95 P/Share
|
|
Apr 29
2022
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
427
+2.01%
|
$9,394
$22.95 P/Share
|
|
Apr 29
2022
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
666
+3.42%
|
$14,652
$22.95 P/Share
|
|
Apr 29
2022
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
394
+1.5%
|
$8,668
$22.95 P/Share
|